首页 | 本学科首页   官方微博 | 高级检索  
检索        

含米托蒽醌化疗方案治疗血液恶性肿瘤的毒副作用临床观察
引用本文:夏梅,刘泽霖,赵德义.含米托蒽醌化疗方案治疗血液恶性肿瘤的毒副作用临床观察[J].广州医学院学报,1994(1).
作者姓名:夏梅  刘泽霖  赵德义
作者单位:Department of Haemotology,Second Affiliated Hospital
摘    要:本文应用含米托蒽醌的化疗方案治疗37例血液恶性肿瘤,观察其毒副作用。结果表明,含米托蒽醌的方案毒副作用有骨髓抑制、胃肠道反应、心肝肾脏器损害、发热等。这些毒副作用症状大多轻微,且易耐受。最为严重的副作用是骨髓抑制,4例死于骨髓抑制后的出血和感染。作者认为,定期复查骨髓象、外周血象和心电图等,加强预防性措施,则可避免其毒性所造成的严重后果,提高血液系统恶性肿瘤的缓解率。

关 键 词:米托蒽醌  血液恶性肿瘤  毒副作用

Clinical Observation of Toxicities of Mitoxantrone in Blood Malignant tumour
Xia Mei,et al.Clinical Observation of Toxicities of Mitoxantrone in Blood Malignant tumour[J].Academic Journal of Guangzhou Medical College,1994(1).
Authors:Xia Mei  
Abstract:This paper reports the toxicities of mitoxantrone in treating 37 cases with blood malignant tumour. The application of mitoxantrone resulted in the toxicities of myelosuppression;gastor-intestinal disturbances; cardiac, hapatic, renal lesion; fever etc. These toxic effects, however, mostly were mild and tolerant. The most severe toxicity was myelosuppession. 4 cases died of bleeding and infection after myelosuppression. The authors considered if we regularly examined the bone marrow,blood cell counts, etc. EKG and strengthen preventive measures,we could then aviod severe results caused by toxicities of mitoxantrone and increased the rate of complete remmission of blood malignant tumour.
Keywords:Mitoxantrone  Blood Malignant Tumour  Toxicities
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号